AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

J. Goldman & Co LP's Holding History (CIK: 0001412741)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 258,600 Value ($000) $1,658 Avg Close $4.86 Range $3.11 - $6.70

Q4 2023

Shares 19,029 Value ($000) $280 Avg Close $15.33 Range $11.82 - $18.88

Q3 2023

Shares 184,907 Value ($000) $3,386 Avg Close $21.15 Range $17.80 - $25.48

Q2 2023

Shares 99,340 Value ($000) $2,143 Avg Close $27.01 Range $20.79 - $31.77

Q1 2023

Shares 68,278 Value ($000) $2,003 Avg Close $34.74 Range $26.64 - $41.93

Q4 2022

Shares 45,642 Value ($000) $1,686 Avg Close $35.49 Range $28.13 - $39.77

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	258,600	$1,658	$4.86	$3.11 - $6.70
Q4 2023	19,029	$280	$15.33	$11.82 - $18.88
Q3 2023	184,907	$3,386	$21.15	$17.80 - $25.48
Q2 2023	99,340	$2,143	$27.01	$20.79 - $31.77
Q1 2023	68,278	$2,003	$34.74	$26.64 - $41.93
Q4 2022	45,642	$1,686	$35.49	$28.13 - $39.77